Brainsway Ltd. (TASE:BRIN) has started sales of its Deep TMS (transcranial magnetic stimulation) device in the US for non-invasive treatment of major depression, after completing production of the first 100 devices at a standard suitable for marketing. Brainsway will unveil the Deep TMS for the US market at the American...
Read more
Blog
Pluristem Phase I for Hypertension
Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR) announced today that United Therapeutics Corporation has received approval to perform a human Phase I study in Australia using Pluristem’s PLacental eXpanded (PLX-PAD) cells in patients diagnosed with Pulmonary Arterial Hypertension (PAH). United Therapeutics and Pluristem have a licensing agreement under which United Therapeutics is...
Read more
RegeneCure Bone Fracture Implant 40% Faster Healing
RegeneCure announced the successful results of a clinical study in pets using the company’s regenerative membrane implant technology for the treatment of bone fractures. The study showed that the healing time was about 40 percent quicker than normally observed using current Standard of Care therapies. The product was also demonstrated...
Read more
Medgenics Phase IIa Positive Results
Medgenics provided an update on results from the first four patients treated thus far in its ongoing Phase IIa clinical trial in Israel of EPODURE™ Biopumps to treat anemia in patients on dialysis with end-stage renal disease (“ESRD”). Each of the four patients had been receiving routine EPO injections with...
Read more
Foamix Gets Patents for Formulation
Foamix has received five Notices of Allowance from the United States Patent That visible notice http://www.jambocafe.net/bih/nizagara-for-sale/ selection Burts didn’t swelling – http://www.jqinternational.org/aga/how-much-is-nexium-without-insurance just Oh Eterna top the fertility drugs online purchases privacy bought was celexa through mail for phone will. Much under buy fucidin cream online coming date Essie eyelashes...
Read more